I think the article mentions that. That said, I would presume the Schedule 1 drugs are being approached with a conservative mindset. But they still mind have wider application once the med profession gets past the stigma. The point being, abandoning these new options should be given a fair chance even if there are intials findings like this one.
A keyword was left from the title / headline.